The University of Maryland School of Pharmacy is set to offer the nation’s first master’s degree program in medical cannabis including classes for basic science, clinical use, adverse effects and public health, and federal and state laws and policies.
The two-year MS in Medical Cannabis Science and Therapeutics program will be based at Rockville, Maryland’s Universities at Shady Grove as well as online. The program also includes an in-person symposium each semester for networking opportunities.
Natalie D. Eddington, PhD, dean and professor of the School of Pharmacy, said that medical cannabis programs will expand throughout the U.S. and its territories which will fuel “a demand for an educated workforce that is well-trained in both the science and therapeutic effects” of medical cannabis.
“Our MS in Medical Cannabis Science and Therapeutics has been critically designed to prepare students to meet this demand. Innovations in instructional design throughout the curriculum will provide students with the knowledge and skills needed to make a positive impact on communities across the United States.” – Eddington, in a statement
The degree does not require a traditional thesis — instead, students will complete a capstone project featuring a selection of expert seminars, case studies, and discussions.
“[This] is an incredibly unique program,” Leah Sera, assistant professor in the Department of Pharmacy Practice and Science at UMSOP and director of the MS in Medical Cannabis Science and Therapeutics program, said in a press release. “Faculty from the School of Pharmacy who lead courses for the program are experts in both basic and clinical sciences related to the study of medications, and are dedicated to making coursework both interesting and accessible to all students.”
The application deadline for the program is Aug. 15; classes begin Aug. 26.